Bank of America’s Applied Genetic Technologies Corporation AGTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-14,420
| Closed | -$4K | – | 8686 |
|
|
2022
Q3 | $4K | Sell |
14,420
-659
| -4% | -$288 | ﹤0.01% | 7481 |
|
|
2022
Q2 | $12K | Sell |
15,079
-15,079
| -50% | -$13.4K | ﹤0.01% | 7357 |
|
|
2022
Q1 | $32K | Sell |
30,158
-3,298
| -10% | -$5.99K | ﹤0.01% | 7350 |
|
|
2021
Q4 | $64K | Buy |
33,456
+5,454
| +19% | +$13.1K | ﹤0.01% | 7097 |
|
|
2021
Q3 | $84K | Sell |
28,002
-39,902
| -59% | -$142K | ﹤0.01% | 6818 |
|
|
2021
Q2 | $265K | Sell |
67,904
-33,230
| -33% | -$138K | ﹤0.01% | 5885 |
|
|
2021
Q1 | $513K | Buy |
101,134
+81,836
| +424% | +$425K | ﹤0.01% | 5343 |
|
|
2020
Q4 | $79K | Buy |
19,298
+5,301
| +38% | +$26K | ﹤0.01% | 6101 |
|
|
2020
Q3 | $68K | Sell |
13,997
-11,253
| -45% | -$61.5K | ﹤0.01% | 5874 |
|
|
2020
Q2 | $140K | Buy |
25,250
+7,825
| +45% | +$35.8K | ﹤0.01% | 5487 |
|
|
2020
Q1 | $58K | Sell |
17,425
-26,643
| -60% | -$140K | ﹤0.01% | 5807 |
|
|
2019
Q4 | $200K | Sell |
44,068
-18,425
| -29% | -$58.3K | ﹤0.01% | 5638 |
|
|
2019
Q3 | $260K | Buy |
62,493
+21,280
| +52% | +$76.8K | ﹤0.01% | 5504 |
|
|
2019
Q2 | $156K | Sell |
41,213
-4,954
| -11% | -$20.3K | ﹤0.01% | 5776 |
|
|
2019
Q1 | $193K | Sell |
46,167
-102
| -0.2% | -$357 | ﹤0.01% | 5542 |
|
|
2018
Q4 | $115K | Sell |
46,269
-3,184
| -6% | -$18.6K | ﹤0.01% | 5838 |
|
|
2018
Q3 | $361K | Buy |
49,453
+472
| +1% | +$2.07K | ﹤0.01% | 5155 |
|
|
2018
Q2 | $181K | Buy |
48,981
+3,885
| +9% | +$18K | ﹤0.01% | 5473 |
|
|
2018
Q1 | $174K | Sell |
45,096
-3,079
| -6% | -$12.9K | ﹤0.01% | 5451 |
|
|
2017
Q4 | $173K | Hold |
48,175
| – | – | ﹤0.01% | 5476 |
|
|
2017
Q3 | $190K | Sell |
48,175
-4,183
| -8% | -$19.2K | ﹤0.01% | 5410 |
|
|
2017
Q2 | $267K | Buy |
52,358
+1,935
| +4% | +$10.9K | ﹤0.01% | 5191 |
|
|
2017
Q1 | $348K | Sell |
50,423
-570
| -1% | -$4.45K | ﹤0.01% | 5071 |
|
|
2016
Q4 | $476K | Buy |
50,993
+13,131
| +35% | +$118K | ﹤0.01% | 4832 |
|
|
2016
Q3 | $370K | Buy |
37,862
+28,497
| +304% | +$384K | ﹤0.01% | 4819 |
|
|
2016
Q2 | $132K | Buy |
9,365
+3,423
| +58% | +$53.4K | ﹤0.01% | 5402 |
|
|
2016
Q1 | $83K | Sell |
5,942
-2,430
| -29% | -$35.6K | ﹤0.01% | 5567 |
|
|
2015
Q4 | $171K | Buy |
8,372
+5,263
| +169% | +$81.2K | ﹤0.01% | 5477 |
|
|
2015
Q3 | $41K | Sell |
3,109
-282
| -8% | -$4.68K | ﹤0.01% | 6028 |
|
|
2015
Q2 | $52K | Buy |
3,391
+296
| +10% | +$5.68K | ﹤0.01% | 5923 |
|
|
2015
Q1 | $62K | Buy |
3,095
+16
| +0.5% | +$358 | ﹤0.01% | 5561 |
|
|
2014
Q4 | $65K | Buy |
+3,079
| New | +$62.7K | ﹤0.01% | 6174 |
|
Bank of America's AGTC Position: Q4 2022 in Review
Bank of America sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 14,420 shares — an estimated $4K sold.
Bank of America first reported a position in AGTC in Q4 2014 and held it in 32 quarters. The position peaked at $513K in Q1 2021. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.
- Bank of America reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
- Bank of America sold 14,420 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $4K.
- Bank of America first reported a position in Applied Genetic Technologies Corporation in Q4 2014 and held it in 32 quarters.
- Bank of America's Applied Genetic Technologies Corporation position peaked at $513K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.
Based on Bank of America's 13F filing for Q4 2022, filed 10 Feb 2023.